Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Award Details
- Contract Award Date: Sep 23, 2024
- Contract Award Number: 75A50124C00046
- Task/Delivery Order Number:
- Contractor Awarded Unique Entity ID: KJJQRRLY2FL5
- Contractor Awarded Name: CERUS CORPORATION
- Contractor Awarded Address: Concord, CA 94520 USA
- Base and All Options Value (Total Contract Value): $248,591,407.65
General Information
- Contract Opportunity Type: Award Notice (Original)
- Original Published Date: Oct 07, 2024 10:16 am EDT
- Inactive Policy: 15 days after contract award date
- Original Inactive Date: Oct 08, 2024
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: Concord , CA 94520USA
Description
License pathogen reduction technology (PRT) for red blood cell (RBC) components to reduce the risk of transfusion-transmitted infection (TTI) by recognized emerging, epidemic, and endemic pathogens that is capable of treating over 10 million RBC components per year.
Attachments/Links
Contact Information
Contracting Office Address
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
Primary Point of Contact
- Joann Kambaja, Contract Specialist
- Joann.Kambaja@hhs.gov
Secondary Point of Contact
History
- Oct 08, 2024 11:55 pm EDTAward Notice (Original)
- May 31, 2024 12:17 pm EDTSolicitation (Updated)